Sio Capital Management, LLC Fusion Pharmaceuticals Inc. Transaction History

Sio Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.9 - $21.32 $23,707 - $63,981	-3,001 Reduced 1.22%	243,035 $5.18 Million
Q1 2023 May 12, 2023	SELL	$3.03 - $5.13 $43,668 - $73,933	-14,412 Reduced 5.53%	246,036 $927,000
Q2 2022 Aug 15, 2022	BUY	$2.49 - $7.86 $1,705 - $5,384	685 Added 0.26%	260,448 $649,000
Q3 2021 Nov 15, 2021	SELL	$7.83 - $9.41 $49,673 - $59,697	-6,344 Reduced 2.38%	259,763 $2.06 Million
Q2 2021 Aug 16, 2021	BUY	$7.97 - $10.66 $133,003 - $177,894	16,688 Added 6.69%	266,107 $2.15 Million
Q1 2021 May 14, 2021	BUY	$9.75 - $13.09 $748,078 - $1 Million	76,726 Added 44.43%	249,419 $2.67 Million
Q4 2020 Feb 16, 2021	BUY	$11.5 - $13.73 $1.99 Million - $2.37 Million	172,693 New	172,693 $2.03 Million
Q3 2020 Nov 16, 2020	SELL	$11.8 - $17.1 $35,400 - $51,300	-3,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$17.0 - $17.78 $51,000 - $53,340	3,000 New	3,000 $52,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.